Four Stocks Beat Earnings the Same Week. Three Fell Anyway — and the Fourth Barely Beat at All

Four companies reported earnings within a 24-hour window on August 5-6, 2026. All four beat Wall Street's estimates on the headline numbers. Three of the four stocks fell — one by more than 14% — and the fourth, which delivered the weakest headline growth of the group, rose 12.6%. Read individually, each of these looks like a puzzle. Read together, they show the same mechanism working four different ways: a stock's reaction to earnings prices the gap between the result and what the market had already built into the share price, not the quality of the quarter by itself.

Envista (NVST), the dental-products company behind DEXIS, Kerr, Nobel Biocare and Ormco, beat both earnings ($0.41 per share versus $0.34 estimated) and revenue ($730.5 million versus $716.05 million estimated), and raised its full-year outlook for core sales growth, adjusted EBITDA, and adjusted EPS. The stock fell 14.3%. A beat-and-raise quarter still falls when the size of the raise comes in below what was already priced in.

Figma (FIG) grew revenue 48% year over year to $370.08 million, beat estimates, and raised its full-year revenue forecast by $40 million — its third straight quarter of accelerating growth. The stock fell 13.7% on a next-quarter guide investors read as too conservative for a company that has spent the year telling an AI-adoption growth story. For a recently public, high-growth stock, the question after any quarter is less about the quarter that just closed and more about whether the next one still shows acceleration.

Sunrun (RUN) beat revenue estimates by 19.2% — $869.99 million versus $751.83 million expected — and fell 12.4% after cutting its 2026 guidance for subscriber value and cash generation on the same call, citing slower sales-staff onboarding and uncertainty around tax-equity pricing and federal solar tax credits. A revenue beat describes the quarter that closed; a subscriber-value cut describes what the company itself now expects those installations to be worth over their lifetime — and the market weighted the second number more heavily.

ZoomInfo (GTM) is the mirror image of the other three. Revenue grew just 1.2% year over year, essentially flat, though it still beat the $301.46 million estimate, and next-quarter guidance came in 1.6% above forecasts. The stock rose 12.6%. After several quarters of decelerating growth, the bar had fallen low enough that merely clearing it — rather than exceeding it by any meaningful margin — was enough to trigger a relief rally.

The lesson across all four: 'beat estimates' is not one signal, it is a comparison against a moving target, and the target moves based on the company's own trajectory and what investors had already assumed about where guidance was headed. A quarter can be objectively strong and still disappoint, or objectively weak and still relieve, depending entirely on where expectations sat beforehand.